Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ASND

Recent news which mentions ASND

< Previous 1 2 3 4 5 Next >
$100 Invested In This Stock 10 Years Ago Would Be Worth $6,500 Today
Tickers ASND NEWS
Tags News BZI/POD Market News
From Benzinga
FDA Pushes Review Date For Ascendis Pharma's Hormone Disorder Candidate By Three Months
Tickers ASND NEWS
Tags Large Cap Biotech Briefs
From Benzinga
$100 Invested In Ascendis Pharma 15 Years Ago Would Be Worth This Much Today
Tickers ASND NEWS
Tags BZI/POD News ASND
From Benzinga
ASND Stock Earnings: Ascendis Pharma Reported Results for Q1 2024
Tickers ASND
Tags Market News Earnings Reports NASDAQ:ASND
From InvestorPlace
Looking Into Ascendis Pharma's Recent Short Interest
Tickers ASND
Tags Short Ideas BZI/SHORTHIST Market News
From Benzinga
$1000 Invested In Ascendis Pharma 15 Years Ago Would Be Worth This Much Today
Tickers ASND NEWS
Tags News BZI/POD Market News
From Benzinga
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years
Tickers ASND NEWS
Tags News BZI/POD Market News
From Benzinga
Here's How Much $100 Invested In Ascendis Pharma 15 Years Ago Would Be Worth Today
Tickers ASND NEWS
Tags News BZI/POD Market News
From Benzinga
These Five Small-Cap Stocks Under The Radar Are Expected To Surge, Says Stock Researcher
Tickers AAPL AMZN ASND FIX
Tags AMZN General News
From Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $45,000 Today
Tickers ASND NEWS
Tags BZI/POD News ASND
From Benzinga
How Is The Market Feeling About Ascendis Pharma?
Tickers ASND
Tags Short Sellers Benzinga ASND
From Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $70,000 Today
Tickers ASND NEWS
Tags Market News Benzinga Trading Ideas
From Benzinga
Earnings Scheduled For February 7, 2024
Tickers ACLS ADN ADNT ALCO
Tags FLNG MAT BG
From Benzinga
Ascendis Pharma's Earnings: A Preview
Tickers ASND
Tags Benzinga ASND BZI/EP
From Benzinga
$100 Invested In Ascendis Pharma 5 Years Ago Would Be Worth This Much Today
Tickers ASND NEWS
Tags Market News Benzinga Trading Ideas
From Benzinga
Ascendis Pharma's Growth Hormone Deficiency Candidate Outperforms in Phase 3 Trial
Tickers ASND
Tags Market News FDA Benzinga
From Benzinga
Analyst Expectations for Ascendis Pharma's Future
Tickers ASND
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
Recap: Ascendis Pharma Q3 Earnings
Tickers ASND
Tags BZI/Recaps Market News Earnings
From Benzinga
Preview: Ascendis Pharma's Earnings
Tickers ASND
Tags ASND Benzinga Market News
From Benzinga
The Latest Analyst Ratings for Ascendis Pharma
Tickers ASND
Tags BZI/AAR ASND Benzinga
From Benzinga
Impact on BioMarin's Sentiment: Voxzogo's Triumph Clouded by Uncertainty
Tickers ASND BBIO BMRN
Tags Initiation ASND Expert Ideas
From Benzinga
The Latest Analyst Ratings for Ascendis Pharma
Tickers ASND
Tags Benzinga ASND BZI/AAR
From Benzinga
Earnings Scheduled For September 5, 2023
Tickers ASAN ASND AVAV BRC
Tags BRC HQY TSEM
From Benzinga
Earnings Preview For Ascendis Pharma
Tickers ASND
Tags BZI/EP Earnings Market News
From Benzinga
Analyst Expectations for Ascendis Pharma's Future
Tickers ASND
Tags Analyst Ratings Market News ASND
From Benzinga
Where Ascendis Pharma Stands With Analysts
Tickers ASND
Tags Benzinga BZI/AAR ASND
From Benzinga
The Latest Analyst Ratings for Ascendis Pharma
Tickers ASND
Tags Benzinga ASND BZI/AAR
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Tickers APLT ASND CPHI KRBP
Tags NERV PLRX CPHI
From Benzinga
FDA Rejects Ascendis Pharma's TransCon PTH For Hypoparathyroidism
Tickers ASND
Tags Movers News why it's moving
From Benzinga
Why Shares of Ascendis Pharma Are Climbing Monday
Tickers ASND
Tags Recent Press Releases ASND Market News
From Motley Fool
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.